 |
|
 |
|
|
|
|
|
Select a location on the map above or from this drop-down list:
|
|
| Talecris Biotherapeutics, Inc. |
PO Box 110526
4101 Research Commons
79 T.W. Alexander Drive
Research Triangle Park, NC 27709
USA
Telephone: 919-316-6300
www.talecris.com
|
|
| Talecris Biotherapeutics |
8368 US 70 West
Clayton, North Carolina 27520
USA
|
|
| Talecris Biotherapeutics, GmbH |
Lyoner Strasse, 15
D- 60528 Frankfurt am Main Niederrad
Deutschland
Telephone: (+49)-69-(0)-660-593-100
Fax: (+49)-69-(0)-660-593-110
www.talecris.com/eu
|
|
| Talecris Biotherapeutics Ltd. |
5800 Explorer Drive, Suite 300
Mississauga, Ontario L4W 5K9
Canada
Telephone: 905-614-5575
No Charge-Dial: 866-482-5226
www.talecris.com/ca
|
|
 |
|
|
|
| Precision Pharma Services, Inc. |
155 Duryea Road
Melville, NY 11747
USA
Telephone: 631-752-7314
www.precisionpharma.com
|
|
| Talecris Plasma Resources |
4401 Research Commons
79 T.W. Alexander Drive
Research Triangle Park, NC 27709
USA
www.talecrisplasma.com
|
|
85 T.W. Alexander Drive
PO Box 110526
Research Triangle Park, NC 27709
USA
919-316-6019
|
 North Carolina State University –
Centennial Campus (Bioanalytics) |
1017 Main Campus Drive
Suite 1200
Raleigh, NC 27606
USA
919-508-9190
|
| Raleigh Test Lab (Nucleic Acid Technologies) |
1200 New Hope Road
Raleigh, NC 27610
USA
919-250-5079
|
| Talecris Biotherapeutics Ltd. |
1785 Alta Vista Drive, Suite 103
Ottawa, Ontario
Canada
Telephone: 613-730-3900
|
|
|
|
|
Important Safety Information
Prolastin®, Alpha1-Proteinase Inhibitor (Human) is indicated for chronic replacement therapy of individuals having congenital deficiency of alpha-1 PI (alpha1-antitrypsin deficiency) with clinically demonstrable panacinar emphysema. Weekly Prolastin® therapy has demonstrated a low occurrence of side effects. In clinical studies with Prolastin®, reactions were observed in 1.16% of infusions, the most common events being fever (0.77%), light-headedness (0.19%), and dizziness (0.19%). As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated. Individuals with selective IgA deficiencies who have known antibody against IgA (anti-IgA antibody) should not receive Prolastin®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present.
You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please click here for Prolastin® full Prescribing Information.
Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor or healthcare provider if you have any questions about your health or any of your medications.
|
|
|
|
|
|